Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology.
Front Pharmacol
; 14: 940129, 2023.
Article
in En
| MEDLINE
| ID: mdl-37234710
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Front Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
India